Hereditary hemorrhagic teleangiectasia;Hereditäre hämorrhagische Teleangiektasie (Morbus Osler-Weber-Rendu)

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 49, 2003, Pages 2593-2597

  Ocran, K ^a,b   Forster U ^a   Haake, K ^a   Wermke, W ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

ANGIODYSPLASIA; ARTERIOVENOUS MALFORMATION; ARTIFICIAL EMBOLISM; CLINICAL FEATURE; CRYOTHERAPY; GENETIC DISORDER; HUMAN; LASER COAGULATION; NEUROSURGERY; RENDU OSLER WEBER DISEASE; REVIEW; SCREENING TEST; STEREOTAXIC SURGERY; SYMPTOMATOLOGY; TELANGIECTASIA;

ARTERIOVENOUS MALFORMATIONS; DIAGNOSIS, DIFFERENTIAL; EPISTAXIS; HUMANS; INCIDENCE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 0347589387     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-45199     Document Type: Review

References (52)

1. Bauer T, Britton P, Lomas D et al. Liver transplantation for hepatic arteriovenous malformation in hereditary haemorrhagic telangiectasia. J Hepatol 1995; 22: 586-590
2. Berendes J. HNO-Heilkunde in Praxis und Klinik. 2. Aufl. (Hrsg). Georg-Thieme Verlag, 1979
3. Bergler W, Gotte K, Riedel F et al. Die Argon-Plasma-Koagulation in der Behandlung von hereditaren hamorrhagischen Teleangiektasien der Nasenschleimhaut. (Argon plasma coagulation in treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa). HNO 1998; 46: 228-232
4. Bergler W, Riedel F, Baker-Schreyer A et al. Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia. Laryngoscope 1999; 109: 15-20
5. Boillot O, Bianco F, Viale JP et al. Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. Gastroenterology 1999; 116: 187-192
6. Braverman IM, Keh A, Jacobson BS. Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Invest Dermatol 1990; 95: 422-427
7. Brohee D, Franken P, Fievez M et al. High-output right ventricular failure secondary to hepatic arteriovenous microfistulae. Selective arterial embolization treatment. Arch Intern Med 1984; 144: 1282-1284
8. Burke CM, Raffin TA. Pulmonary arteriovenous malformations, aneurysms and reflections. Chest 1986; 89: 771-772
9. Buscarini E, Buscarini L, Danesino C et al. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family. J Hepatol 1997; 26: 111-118
10. Caselitz M, Wagner S, Chavan A et al. Clinical outcome of transfemoral embolisation in patients with arteriovenous malformations of the liver in hereditary haemorrhagic telangiectasia (Weber-Rendu-Osler disease). Gut 1998; 42: 123-126
11. Gluckman JL, Portugal LG. Modified Young's procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia. Laryngoscope 1994; 104: 1174-1177
12. Golding-Wood PH. The role of arterial ligation in intractable epistaxis. J Laryngol Otol 1983; : 8120-8122(Suppl
13. Gothlin JH, Nordgard K, Jonsson K et al. Hepatic telangiectasia in Osler's disease treated with arterial embolization: Report of 2 cases. Eur J Radiol 1982; 2: 27-30
14. Guttmacher AE, Marchuk DA, White RI. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995; 333: 918-924
15. Haitjema T, Disch F, Overtoom TT et al. Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 1995; 99: 519-524
16. Haitjema T, Westermann CJ, Overtoom TT et al. Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights in pathogenesis, complications, and treatment. Arch Intern Med 1996; 156: 714-719
17. Hanes FM. Multiple hereditary telangiectasee cause hemorrhage (herditary hemorrhagic telangiectasia). Bull Johns Hopkins Hosp 1909; 20: 63-73
18. Jackson JE. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: treatment with embolization. Radiology 1999; 213: 927-928
19. Jahnke V. Zur Feinstriktur des Morbus Rendu-Osler-Weber. (Fine structure in Rendu-Osler-Weber's disease). Arch Klin Exp Ohren Nasen Kehlkopfheilkd 1971; 199: 610-614
20. Johnson DW, Berg JN, Baldwin MA et al. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 1996; 13: 189-195
21. Kjeldsen AD, Oxhoj H, Andersen PE et al. Pulmonary arteriovenous malformations: screening procedures and pulmonary angiography in patients with hereditary hemorrhagic telangiectasia. Chest 1999; 116: 432-439
22. Lennox PA, Harries M, Lund VJ et al. A retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia. J Laryngol Otol 1997; 111: 34-37
23. Mager JJ, Westermann CJ. Value of capillary microscopy in the diagnosis of hereditary hemorrhagic telangiectasia. Arch Dermatol 2000; 136: 732-734
24. Maher CO, Piepgras DG, Brown R-DJ et al. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 2001; 32: 877-882
25. Mathus-Vliegen EM. Laser treatment of intestinal vascular abnormalities. Int J Colorectal Dis 1989; 4: 20-25
26. Matsubara S, Manzia JL, ter Brugge K et al. Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. Am J Neuroradiol 2000; 21: 1016-1020
27. McAllister KA, Grogg KM, Johnson DW et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 1994; 8: 345-351
28. Neumann UP, Knoop M, Langrehr JM et al. Effective therapy for hepatic M. Osler with systemic hypercirculation by ligation of the hepatic artery and subsequent liver transplantation. Transpl Int 1998; 11: 323-326
29. Ocran K, Rickes S, Neye H et al. Dopplersonographische Leberbefunde bei M Osier. Ultraschall Med 2001; 22: S38-S39
30. Odorico JS, Hakim MN, Becker YT et al. Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia. Liver Transpl Surg 1998; 4: 483-490
31. Olivieri C, Mira E, Delu G et al. Identification of 13 new mutations in the ACVRL1 gene in a group of 52 unselected Italian patients affected by hereditary haemorrhagic telangiectasia. J Med Genet 2002; 39: E39
32. Osler W. On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Bull Johns Hopkins Hosp 1901; 12: 333-?33
33. Piantanida M, Buscarini E, Dellavecchia C et al. Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2. J Med Genet 1996; 33: 441-444
34. Plauchu H, de Chadarevian JP, Bideau A et al. Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989; 32: 291-297
35. Porteous ME, Curtis A, Williams O et al. Genetic heterogeneity in hereditary haemorrhagic telangiectasia. J Med Genet 1994; 31: 925-926
36. Radtke WE, Smith HC, Fulton RE et al. Misdiagnosis of atrial septal defect in patients with hereditary telangiectasia (Osler-Weber-Rendu disease) and hepatic arteriovenous fistulas. Am Heart J 1978; 95: 235-242
37. Reilly PJ, Nostrant TT. Clinical manifestations of hereditary hemorrhagic telangiectasia. Am J Gastroenterol 1984; 79: 363-367
38. Rendu HJ. Épistaxis répétées chez un sujet porteur de petits angiomes cutanés et muqueux. Bull Soc Med Hop (Paris) 1896; 13: 731-733
39. Sargeant IR, Loizou LA, Rampton D et al. Laser ablation of upper gastrointestinal vascular ectasias: long term results. Gut 1993; 34: 470-475
40. Saunders WH. Epistaxis. Minn Med 1967; 50: 849-854
41. Saunders WH. Septal dermoplasty - ten years experience. Trans Am Acad Ophthalmol Otolaryngol 1968; 72: 153-160
42. Shovlin CL, Guttmacher AE, Buscarini E et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91: 66-67
43. Shovlin CL, Hughes JM, Tuddenham EG et al. A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 1994; 6: 205-209
44. Shovlin CL, Letarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999; 54: 714-729
45. Stockx L, Raat H, Caerts B et al. Transcatheter embolization of hepatic arteriovenous fistulas in Rendu-Osler-Weber disease: a case report and review of the literature. Eur Radiol 1999; 9: 1434-1437
46. Trotter JF, Suhocki PV, Lina JR et al. Hereditary hemorrhagic telangiectasia causing high output cardiac failure: treatment with transcatheter embolization. Am J Gastroenterol 1998; 93: 1569-1571
47. Van Cutsem E, Rutgeerts P, Geboes K et al. Estrogen-progesterone treatment of Osler-Weber-Rendu disease. J Clin Gastroenterol 1988; 10: 676-679
48. Vincent P, Plauchu H, Hazan J et al. A third locus for hereditary haemorrhagic telangiectasia maps to chromosome 12q. Hum Mol Genet 1995; 4: 945-949
49. Weber FP. Multiple heriditary developmental angiomata (telangiectases) of the skin and mucous membranes associated with recurring haemorrhages. Lancet 1907; 2: 160-162
50. Werner JA, Lippert BM, Geisthoff UW et al. Nd:YAG-Lasertherapie der rezidivierenden Epistaxis bei hereditarer hamorrhagischer Teleangiektasie. (Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia). Laryngorhinootologie 1997; 76: 495-501
51. White RI, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996; 7: 787-804
52. Zentler-Munro PL, Howard ER, Karani J et al. Variceal haemorrhage in hereditary haemorrhagic telangiectasia. Gut 1989; 30: 1293-1297